Avanos Medical (AVNS) Shares Outstanding (2013 - 2026)

Avanos Medical has reported Shares Outstanding (Entity) for 14 years, with the latest figure at $46.7 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 0.94% year-over-year to $46.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.7 million (up 0.94% YoY) and the FY2025 annual result came in at $46.5 million, up 1.07% from the prior year.
• Shares Outstanding (Entity) held at $46.7 million in Q1 2026 per AVNS's latest filing, from $46.5 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $47.3 million in Q1 2022 and troughed at $45.9 million in Q2 2024.
• A 5-year average of $46.4 million and a median of $46.4 million in 2023 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) slipped 3.48% in 2022, then increased 1.07% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $46.5 million in 2022, then decreased by 0.76% to $46.2 million in 2023, then slipped by 0.46% to $46.0 million in 2024, then increased by 1.07% to $46.5 million in 2025, then climbed by 0.47% to $46.7 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $46.7 million, $46.5 million, and $46.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.